• About Us
  • Our Approach
    • Discovery Platform
  • Pipeline
    • HMBD-001
    • HMBD-002
    • HMBD-501
  • News
  • Careers

What are you looking for?

Hummingbird Bioscience
Hummingbird Bioscience
Hummingbird Bioscience
  • About Us
  • Our Approach
    • Discovery Platform
  • Pipeline
    • HMBD-001
    • HMBD-002
    • HMBD-501
  • News
  • Careers

SITC 2022: Anti-VISTA antibody HMBD-002 reprograms tumor associated macrophages and promotes cytotoxic T cell response

by hbs-admin on 16 November, 2022 in Publications & Posters, Publications & Posters - 2022

<< Back to News

SITC 2022: Anti-VISTA antibody HMBD-002 reprograms tumor associated macrophages and promotes cytotoxic T cell response

16 November, 2022
VIEW POSTER

<< Back to News

PubPosts-HMBD-002RelatedNews-HMBD-002
Previous Reading
SITC 2022: Trial in Progress: A phase 1 first-in-human study of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, as a monotherapy and combined with pembrolizumab in patients with advanced solid malignancies
Next Reading
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy

Leave a Reply Cancel reply

You must be logged in to post a comment.

Hummingbird Bioscience

TMC Innovation
2450 Holcombe Blvd, Suite X
Houston, TX 77021

The Galen
61 Science Park Road, #06-15/24,
Singapore 117525

For general enquiries, please contact contact@hummingbirdbio.com

For career enquiries, please contact careers@hummingbirdbio.com

For business development opportunities, please contact bd@hummingbirdbio.com


Hummingbird Bioscience Twitter Hummingbird Bioscience Twitter Hummingbird Bioscience LinkedinHummingbird Bioscience Linkedin Hummingbird Bioscience YouTube Hummingbird Bioscience YouTube
Subscribe to our updates
Registered Company No: 201505192N
PRIVACY POLICY | © 2022 Hummingbird Bioscience

Subscribe to our updates

    *indicates required

    GDPR Marketing Permissions

    *Please select all the ways you would like to hear from Hummingbird Bioscience:

    You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website. For questions about this mailing list, please email communications@hummingbirdbio.com

    We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.